HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$7.51
Day range
$7.34 - $7.72
Year range
$4.09 - $17.24
Market cap
160.32M USD
Avg Volume
155.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 14.93M | -12.48% |
Operating expense | 39.45M | -20.81% |
Net income | -22.64M | 27.32% |
Net profit margin | -151.71 | 16.96% |
Earnings per share | -1.06 | 27.89% |
EBITDA | -23.32M | 27.44% |
Effective tax rate | 5.45% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 193.38M | -35.61% |
Total assets | 322.99M | -21.90% |
Total liabilities | 229.46M | -7.27% |
Total equity | 93.54M | — |
Shares outstanding | 21.38M | — |
Price to book | 1.71 | — |
Return on assets | -18.26% | — |
Return on capital | -19.08% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -22.64M | 27.32% |
Cash from operations | -13.49M | 52.84% |
Cash from investing | -4.37M | -107.45% |
Cash from financing | -6.89M | -7.37% |
Net change in cash | -24.74M | -204.81% |
Free cash flow | -13.31M | 28.85% |
About
Founded
1995
Headquarters
Website
Employees
131
